Biomics Biopharma (ASX:BBM) Other Financing: A$0.00 Mil (TTM As of . 20)


What is Biomics Biopharma Other Financing?

Biomics Biopharma ASX:BBM Other Financing is A$0.00 Mil as of . 20.

Biomics Biopharma's Other Financing for the six months ended in . 20 was A$0.00 Mil.

Biomics Biopharma's Other Financing for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

Biomics Biopharma Other Financing Historical Data

* Premium members only.

The historical data trend for Biomics Biopharma's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma Other Financing Chart

Biomics Biopharma Annual Data
Trend
Other Financing

Biomics Biopharma Semi-Annual Data
Other Financing

Biomics Biopharma Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of A$0.00 Mil mean?
Biomics Biopharma (ASX:BBM) has a Other Financing of A$0.00 Mil as of . 20. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Biomics Biopharma and its competitors.
Is Biomics Biopharma's Other Financing too high?
Biomics Biopharma's current Other Financing is A$0.00 Mil.
How does Biomics Biopharma's Other Financing compare to competitors?
Biomics Biopharma's Other Financing of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Biomics Biopharma and its competitors. Biomics Biopharma's current Other Financing is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomics Biopharma stock overvalued right now?
Biomics Biopharma (ASX:BBM) has a current Other Financing of A$0.00 Mil. The current Other Financing is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Biomics Biopharma (ASX:BBM), the current Other Financing is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomics Biopharma Business Description

Address 1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.